Navigation Links
Zimmer Presents Trabecular Metal Technology Experience at AAOS Annual Meeting
Date:2/25/2009

believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
3. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
4. Zimmer Holdings to Present at Upcoming Investor Conferences
5. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
6. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
7. Zimmer Holdings to Present at JPMorgan Healthcare Conference
8. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
9. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
10. Zimmer Reports Fourth Quarter and 2007 Financial Results
11. Zimmer Holdings to Present at Merrill Lynch Health Care Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ings support link between mental and physical heal...-- Being depressed might take as many years off yo..., However, a combination of depression and anxiety...ession. , Researchers came to their conclusions...e than 60,000 people. During the four years after ...
(Date:11/23/2009).... November 23, 2009 In the November issue of GI...eviewed scientific journal of the American Society...t of Stanford University found that Barrett,s esop...women undergoing endoscopic screening. Also in thi...d (EUS): Researchers from France, in the largest s...
(Date:11/23/2009)...- A Loyola University Health System study has foun...y obese -- approximately 100 pounds or more overwe...f U.S. adults with Type 2 diabetes are obese, and ...rican adults with Type 2 diabetes, 1 in 3 is morbi...eople with diabetes is increasing at a very alarmi...
(Date:11/23/2009).... The United States Department of Agriculture (US...inia Tech and the University of Minnesota to compl...ey, Meleagris gallopavo. The funding will be used ...lete the genome sequencing using next-generation s... and identify genes and functions in the final gen...
(Date:11/23/2009)...ES,Nov.23/PRNewswire-FirstCall/--InstacareCorp.(OT...rybrandsof MD@Hand ,target=,_blank,title=, MD@Hand...et=,_blank,title=, MD@Hand ,> MD@Hand ,> MD@Hand ...et=,_blank,title=, MD@Hand ,target=,_blank,title=,...nd ,target=,_blank,title=, MD@Hand ,> MD@Hand ,> ...
Breaking Medicine News(10 mins):Health News:Depression May Up Death Risk to That of Smoking 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Diabetics show alarming increase in morbid obesity 2Health News:Turkey Genome Sequencing Consortium awarded $0.9 million from USDA 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 3Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 4Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 6Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 7
...ole is counteracting Canada,s ban on direct-to-con...o more than $90 million worth of ads, including th...ng to a study by UBC researchers. , Barbara Mintz...m 1995 to 2006 and saw spending rise from less tha...
... www.aftertheinjury.org to Help Parents and Kids...auma season" is the unfortunate nickname for summe...d increased outdoor activity level brings an estim...icle crashes, water-related accidents, pedestrian ...
....J., May 27 Nuvilex, Inc. (OTC Bulletin Board: N...pany, announced today that Infinitink(TM), the wor...h safe and more easily removed, is the subject of ...t and broaden the audience for this already popula...
... 27 Body shaping will be one of the main acts thi...Eleme Medical, a premier body shaping company, wil...duction and body sculpting procedures, SmoothShape...es patient and star of Bravo,s mega-hit reality sh...
...and SAN FRANCISCO, May 27 WeissComm Group tod...ia Group , a social media consulting company foun...s Chief Technology and Media Officer. WeissComm a... continue to operate and grow this function for We...
...earch Group,s new European dental implant report n...efore , , WALTHAM, Mass., May 27 Millennium Rese...tal Implants 2009 report finds that, despite unfa...oth dentist and patient demand. This new report pr...
Other Medicine News:Health News:Legal loophole exposes Canadians to drug advertising banned in US: UBC research 2Health News:Summertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child Injury 2Health News:Summertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child Injury 3Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 2Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 3Health News:Body Shaping Gets the Spotlight with Industry Experts and Celebrity Guest to Showcase SmoothShapes(R) and SmoothLipo(TM) Systems at THE Aesthetic Show in Las Vegas 2Health News:Body Shaping Gets the Spotlight with Industry Experts and Celebrity Guest to Showcase SmoothShapes(R) and SmoothLipo(TM) Systems at THE Aesthetic Show in Las Vegas 3Health News:WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media 2Health News:WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media 3Health News:WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media 4Health News:Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions 2Health News:Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions 3
(Date:11/23/2009)...RINCETON,N.J.,Nov.23/PRNewswire-FirstCall/--Pharma...lmentofCohort2,ledbyitspartnerRoche(SWX:ROG.VX;RO....ype1and4patientsintheongoingphase2btrialofRG7128,a...orthetreatmentofchronichepatitisCvirus(HCV)infecti...ndependentDataMonitoringCommittee(DMC)ofallavailab...
(Date:11/23/2009)...OVATO,Calif.,Nov.23/PRNewswire-FirstCall/--RaptorP... RPTP ),todayannouncedresultsfromaPhase2bclinicalt...trate("DRCysteamine")inpatientswithnephropathiccys...rsityofCalifornia,SanDiego("UCSD")GeneralClinicalR...okineticsandpharmacodynamicsofasingledoseofDRCyste...
(Date:11/23/2009)...LISOVIEJO,Calif.,Nov.23/PRNewswire-FirstCall/--Oce...als International(NYSE: VRX ),todayannouncedthatit...iniumbromide,anauthorizedgeneric(AG)versionofLibra...tstobeasignificantplayerintheLibrax®genericma...rtantdivisionofourU.S.businesswithitssuccessfullau...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2U S Faces Shortage of Heart Surgeons 56866 1U S Faces Shortage of Heart Surgeons 56866 2U S Faces Shortage of Heart Surgeons 56866 3Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox Restylane Radiesse and Others 56864 1Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox Restylane Radiesse and Others 56864 2Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox Restylane Radiesse and Others 56864 3CBS Radio Presents Cars for Courage Boat Drive Sept 13 56861 1CBS Radio Presents Cars for Courage Boat Drive Sept 13 56861 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: